Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

ClinicalTrials.gov ID: NCT01726270

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01726270. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 1:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Multicenter trial conducted in Pharmacy retail centers

Study identification

NCT ID
NCT01726270
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
689 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2012 (Type not available)
Primary completion
Mar 2013 (Actual)
Completion
Mar 2013 (Actual)
Last update posted
Mar 27, 2020

2012 – 2013

United States locations

U.S. sites
18
U.S. states
8
U.S. cities
18
Facility City State ZIP Site status
Boehringer Ingelheim Investigational Site Hoover Alabama — —
Boehringer Ingelheim Investigational Site Mesa Arizona — —
Boehringer Ingelheim Investigational Site Encino California — —
Boehringer Ingelheim Investigational Site Garden Grove California — —
Boehringer Ingelheim Investigational Site La Habra California — —
Boehringer Ingelheim Investigational Site Anoka Minnesota — —
Boehringer Ingelheim Investigational Site Elk River Minnesota — —
Boehringer Ingelheim Investigational Site Fridley Minnesota — —
Boehringer Ingelheim Investigational Site Roseville Minnesota — —
Boehringer Ingelheim Investigational Site Saint Francis Minnesota — —
Boehringer Ingelheim Investigational Site Albuquerque New Mexico — —
Boehringer Ingelheim Investigational Site Longview Texas — —
Boehringer Ingelheim Investigational Site Tyler Texas — —
Boehringer Ingelheim Investigational Site Bountiful Utah — —
Boehringer Ingelheim Investigational Site Layton Utah — —
Boehringer Ingelheim Investigational Site Salt Lake City Utah — —
Boehringer Ingelheim Investigational Site Syracuse Utah — —
Boehringer Ingelheim Investigational Site Richmond Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01726270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2020 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.